* Treace Medical Concepts Inc TMCI.OQ reported a quarterly
adjusted loss of 10 cents per share for the quarter ended in
June. The mean expectation of four analysts for the quarter was
for a loss of 12 cents per share.
* Revenue was $20.65 million; analysts expected $18.93
million.
* Treace Medical Concepts Inc's reported EPS for the quarter was
a loss of 10 cents.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Treace Medical Concepts Inc shares had fallen by 10.1% this
quarter.
* The company reported a quarterly loss of $5.12 million.
* Wall Street's median 12-month price target for Treace Medical
Concepts Inc is $37.00
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
This summary was machine generated August 6 at 02:27 a.m. All
figures in US dollars unless otherwise stated